Tina Vilsbøll
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management 295
- Diabetes Management and Research 156
- Endocrine and Autonomic Systems top 0.2%
- Surgery top 0.1%
- Pancreatic function and diabetes 128
- Pharmacology top 0.1%
- Pharmacology and Obesity Treatment 32
- Physiology top 0.5%
- Diet and metabolism studies 66
-
- Metabolism, Diabetes, and Cancer 100
-
- Liver Disease Diagnosis and Treatment 31
-
- Diabetes and associated disorders 23
- Co-authors
- Filip K. KnopJens J. HolstThure KrarupSten MadsbadMikkel ChristensenAsger LundCarolyn F. DeaconLise Lotte Gluud
- Journals
- New England Journal of Medicine (1 paper)JAMA (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Tina Vilsbøll
434 papers receiving 19.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Endocrinology, Diabetes and Metabolism 14.9k
- Endocrine and Autonomic Systems 1.5k
- Surgery 8.1k
- Pharmacology 2.6k
- Physiology 3.4k
Countries citing papers authored by Tina Vilsbøll
This map shows the geographic impact of Tina Vilsbøll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Vilsbøll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Vilsbøll more than expected).
Fields of papers citing papers by Tina Vilsbøll
This network shows the impact of papers produced by Tina Vilsbøll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Vilsbøll. The network helps show where Tina Vilsbøll may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tina Vilsbøll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 9 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 16 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 19 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 34 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 16 | |
| 15 | 2019 | 15 | |
| 16 | 2018 | 45 | |
| 17 | 2017 | 75 | |
| 18 | 2016 | 66 | |
| 19 | Glucagon-like peptide-1 and diabetes treatment | 2009 | 1 |
| 20 | Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus. | 2009 | 60 |
About Tina Vilsbøll
Tina Vilsbøll is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Endocrine and Autonomic Systems, having authored 455 papers that have together received 20.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (295 papers), Diabetes Management and Research (156 papers), Pancreatic function and diabetes (128 papers), Metabolism, Diabetes, and Cancer (100 papers), Diet and metabolism studies (66 papers), Pharmacology and Obesity Treatment (32 papers), Liver Disease Diagnosis and Treatment (31 papers) and Diabetes and associated disorders (23 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (14.9k citations), Endocrine and Autonomic Systems (1.5k citations) and Surgery (8.1k citations). Tina Vilsbøll has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Filip K. Knop, Jens J. Holst, Thure Krarup, Sten Madsbad, Mikkel Christensen, Asger Lund, Carolyn F. Deacon, Lise Lotte Gluud, Jonatan I. Bagger and Bolette Hartmann. Their work appears in journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.